InMode Ltd. designs, develops, manufactures, and markets minimally invasive and non-invasive aesthetic medical devices for body contouring, skin rejuvenation, and women's health procedures. The company's core technology platform centers on proprietary radiofrequency-assisted lipolysis and deep subdermal fractional radiofrequency systems. Its product portfolio addresses procedures including liposuction with simultaneous skin tightening, facial rejuvenation, permanent hair reduction, cellulite treatment, wrinkle reduction, and muscle stimulation. The company also offers hands-free aesthetic devices targeting skin tightening, fat reduction, and muscle activation.
InMode operates through a global distribution network covering the United States, Canada, United Kingdom, Ireland, Spain, Portugal, France, Belgium, Luxembourg, Italy, Germany, Austria, Japan, Australia, and India. The company distributes its products through third-party distributors rather than maintaining direct sales operations in most markets. InMode was incorporated in Israel in 2008 under its original name, Invasix Ltd., and rebranded to InMode Ltd. in November 2017.
The company employs approximately 660 full-time employees and maintains headquarters in Yokne'am, Israel. InMode's business operates within the electromedical and electrotherapeutic apparatus segment of the medical devices industry.
No 10-K filings found.